Artelo Biosciences Inc.

NASDAQ: ARTL · Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT

Artelo Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Net Income
-12.43M -10.86M -10.97M -10.27M -10.44M -9.6M -9.29M -9.55M -9.44M -10.29M -10.08M -9.29M -8.85M -8.65M -8.55M -7.44M -6.58M -5.28M
Depreciation & Amortization
54K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 61.00 123.00 183.00 311.00 374.00
Stock-Based Compensation
548K 626K 647K 665K 849K 879K 1.02M 1.41M 1.79M 2.19M 2.46M 2.42M 2.33M 2.33M 2.05M 1.53M 1.06M 497.17K
Other Working Capital
53K 222.03K 414.03K 548.03K 334.03K 503K 430K 353K 236K 331K -195K -271K -410K -824.55K -204.85K -42.65K 60.33K 88.41K
Other Non-Cash Items
4.92M 3.89M 3.01M 2.88M 1.8M -623K -641K -613K -518K -354K -211K -75K 1.82K 26.15K 5.82K 6.82K n/a -1.33K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
1.39M 1.33M 947.03K 327.03K 447.03K 385K 703K 855K 362K 311K -172K -695K -973.32K -1.01M -254.17K -242K 42.29K 70.37K
Operating Cash Flow
-5.51M -5.02M -6.37M -6.4M -7.34M -8.96M -8.21M -7.9M -7.8M -8.14M -8.01M -7.64M -7.49M -7.3M -6.75M -6.14M -5.47M -4.71M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.18K 1.18K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
10.51M 8.16M 7.67M 6.73M -6.01M -8.36M -13.69M -14.92M -18.19M -16.58M -13.22M -21.8M -13.94M -13.2M -10.76M n/a n/a n/a
Sales Maturities Of Investments
-5.25M -2.5M -752K 2.44M 8.19M 10.94M 17.19M 17.48M 19.51M 21.48M 16.18M 14.08M 9.31M 4.58M 1.88M n/a n/a n/a
Other Investing Acitivies
-813.98K -814.15K -814.15K -814.15K -172 n/a n/a n/a n/a n/a n/a n/a -3.44M -2.93M -2.93M -2.93M 510.69K n/a
Investing Cash Flow
4.44M 4.84M 6.11M 8.35M 2.18M 2.58M 3.51M 2.56M 1.31M 4.9M 2.96M -7.72M -8.07M -11.55M -12.32M -3.44M 1.18K -509.52K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.00 9.00
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.07M 219.83 219.83 219.83 219.83 n/a n/a n/a n/a n/a n/a n/a 1.11M 1.7M 7.02M 6.01M 5.01M 4.32M
Financial Cash Flow
3.13M 57.79K 112.79K 87.79K 622K -630K -685K -583K -1.12M n/a n/a 18.13M 19.72M 20.48M 25.8M 14.11M 14.23M 13.89M
Net Cash Flow
-3.79M -135.31K -163.31K 2.03M -4.52M -5.72M -4.07M -4.5M -6.4M -3.43M -5.27M 2.39M 3.95M 1.53M 6.66M 4.49M 8.77M 8.72M
Free Cash Flow
-6.63M -6.14M -7.49M -7.51M -7.34M -8.96M -8.21M -7.9M -7.8M -8.14M -8.01M -7.64M -7.49M -7.3M -6.75M -6.14M -5.47M -4.71M